Related references
Note: Only part of the references are listed.Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome
Macarena Alpanes et al.
FERTILITY AND STERILITY (2015)
Prospective Association of Polycystic Ovary Syndrome With Coronary Artery Calcification and Carotid-Intima-Media Thickness The Coronary Artery Risk Development in Young Adults Women's Study
Ronit Calderon-Margalit et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
Didier Dewailly et al.
HUMAN REPRODUCTION UPDATE (2014)
Office Blood Pressure, Ambulatory Blood Pressure Monitoring, and Echocardiographic Abnormalities in Women With Polycystic Ovary Syndrome Role of Obesity and Androgen Excess
Manuel Luque-Ramirez et al.
HYPERTENSION (2014)
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
Michael W. O'Reilly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Uche Ezeh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary Syndrome
Paolo Moghetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
OBESITY REVIEWS (2013)
Ethnic differences in the phenotypic expression of polycystic ovary syndrome
Yue Zhao et al.
STEROIDS (2013)
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Harpal S. Randeva et al.
ENDOCRINE REVIEWS (2012)
Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study
Nese Cinar et al.
HUMAN REPRODUCTION (2012)
Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
Raul Sanchon et al.
HUMAN REPRODUCTION (2012)
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
H. F. Escobar-Morreale et al.
HUMAN REPRODUCTION UPDATE (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Obesity impairs general health-related quality of life (HR-QoL) in premenopausal women to a greater extent than polycystic ovary syndrome (PCOS)
Francisco Alvarez-Blasco et al.
CLINICAL ENDOCRINOLOGY (2010)
Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women
Tsan-Hon Liou et al.
FERTILITY AND STERILITY (2009)
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Ricardo Azziz et al.
FERTILITY AND STERILITY (2009)
A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs
Hector F. Escobar-Morreale et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome
Manuel Luque-Ramirez et al.
HUMAN REPRODUCTION (2007)
Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome
Mei-Jou Chen et al.
HYPERTENSION (2007)
Abdominal adiposity and the polycystic ovary syndrome
Hector F. Escobar-Morreale et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women
Francisco Alvarez-Blasco et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children
J Taieb et al.
CLINICAL CHEMISTRY (2003)